OTSKF News and Press, Otsuka Holdings Co. Ltd. From 11/10/23

2023-11-10 10:34:03 ET More on Vera Therapeutics Vera Therapeutics' Promising Atacicept Drug Targets IgAN Guggenheim starts Vera at buy, sees IgAN drug as "well positioned" Seeking Alpha’s Quant Rating on Vera Therapeutics Historical earnings data for ...

2023-09-29 10:00:00 ET More on psychedelic drugs Atai Life Sciences: RL-007, Targeting Schizophrenia Subpopulation With No FDA Approved Therapies With ecstasy a potential PTSD therapy, psychedelic treatments could take off Psychedelic Stocks = Super-Risky Biote...

2023-08-24 06:59:36 ET More on Medtronic Medtronic plc ( MDT ) Q1 2024 Earnings Call Transcript Medtronic plc 2024 Q1 - Results - Earnings Call Presentation Medtronic: Dark Clouds Are Clearing - Outperformance Ahead Medtronic: MiniMed 780G Could Inspire G...

2023-07-31 11:41:57 ET Otsuka Holdings Co., Ltd. press release ( OTCPK:OTSKF ): Q1 GAAP EPS of ¥189.06. Revenue of ¥947.54B (+16.4% Y/Y). For further details see: Otsuka Holdings Co., Ltd. GAAP EPS of ¥189.06, revenue of ¥947.54B

2023-05-12 05:35:59 ET Otsuka Holdings press release ( OTCPK:OTSKF ): Q1 GAAP EPS of ¥113.18. Revenue of ¥448.34B (+17.9% Y/Y). Forecast of Consolidated Financial Results for the Fiscal Year Ending December 31, 2023 : Revenue of ¥1,80...

2023-05-11 16:18:07 ET Summary BioXcel Therapeutics, Inc. is currently in exciting times, awaiting very important clinical trial results in the coming weeks. The recently released BioXcel Therapeutics first-quarter results provided a low revenue figure for IGALMI, however, the mar...

2023-05-11 05:56:21 ET The U.S. Food and Drug Administration (FDA) approved the expanded use of H. Lundbeck ( OTCPK:HLBBF ) ( OTCPK:HLUBF ) and Otsuka's ( OTCPK:OTSKY ) ( OTCPK:OTSKF ) medicine Rexulti (brexpiprazole) to treat agitation associated with dementia due to Alzh...

2023-04-13 15:36:07 ET German biotech Atai Life Sciences ( NASDAQ: ATAI ) added 12% Thursday after announcing investigators have dosed the first participant in a Phase 1 study for PCN-101, a candidate targeted at treatment-resistant depression (TRD). Atai ( ATAI ) comp...

2023-03-29 17:43:48 ET The US FDA has scheduled an advisory committee meeting to evaluate an application from Otsuka ( OTCPK:OTSKF ) and H. Lundbeck ( OTCPK:HLBBF ) to expand the indication for Rexulti (brexipiprazole) to include Alzheimer's disease agitation. The Psy...

Otsuka Holdings Co., Ltd. ( OTCPK:OTSKF ): FY GAAP EPS of ¥246.99. Revenue of ¥1.74B (+16.8% Y/Y). For further details see: Otsuka Holdings Co., Ltd. GAAP EPS of ¥246.99, revenue of ¥1.74B